Clinical Trial Update: A Phase IV Study in Drug-Naive Patients With T2DM in China [Phase 4]

View source ↗

Summary

Phase IV study in drug-naive patients with type 2 diabetes mellitus conducted in China has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Snippet

Sponsor: AstraZeneca | Conditions: Type 2 Diabetes Mellitus | Phase 4 | Status: TERMINATED